Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma

Histopathological characterization of ProMisE molecular groups of endometrial cancer

(2020) Antonio Raffone et al.   GYNECOLOGIC ONCOLOGY

Endometrial Carcinomas with a “Serous” Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations

(2020) Niamh Conlon et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma

(2020) Antonio Travaglino et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups

(2020) Antonio Travaglino et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification

(2020) Soyoun Rachel Kim et al.   GYNECOLOGIC ONCOLOGY

Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer

(2020) Antonio Raffone et al.   PATHOLOGY & ONCOLOGY RESEARCH

TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma

(2020) Antonio Travaglino et al.   PATHOLOGY & ONCOLOGY RESEARCH

Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer

(2020) Antonio Raffone et al.   PATHOLOGY RESEARCH AND PRACTICE

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

(2020) Nicole Concin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer

(2019) Antonio Raffone et al.   APMIS

BAG 3 expression correlates with the grade of dysplasia in squamous intraepithelial lesions of the uterine cervix

(2019) Antonio Raffone et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Nuclear expression of β‐catenin in endometrial hyperplasia as marker of premalignancy

(2019) Antonio Travaglino et al.   APMIS

TCGA molecular groups of endometrial cancer: Pooled data about prognosis

(2019) Antonio Raffone et al.   GYNECOLOGIC ONCOLOGY

Clear cell endometrial carcinoma and the TCGA classification

(2019) Antonio Travaglino et al.   HISTOPATHOLOGY

PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells

(2019) Annukka Pasanen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

(2019) Alicia León‐Castillo et al.   JOURNAL OF PATHOLOGY

TCGA Molecular Subgroups in Endometrial Undifferentiated/Dedifferentiated Carcinoma

(2019) Antonio Travaglino et al.   PATHOLOGY & ONCOLOGY RESEARCH

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

(2018) S Kommoss et al.   ANNALS OF ONCOLOGY

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response

(2018) Daniel Temko et al.   JOURNAL OF PATHOLOGY

Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

(2017) Stefania Bellone et al.   GYNECOLOGIC ONCOLOGY

Blinded histopathological characterisation of POLE exonuclease domain- mutant endometrial cancers: sheep in wolf's clothing

(2017) Inge C Van Gool et al.   HISTOPATHOLOGY

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

(2017) Florine A. Eggink et al.   OncoImmunology

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

(2016) Ellen Stelloo et al.   CLINICAL CANCER RESEARCH

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

(2016) Janice M. Mehnert et al.   JOURNAL OF CLINICAL INVESTIGATION

Synthesizing Evidence from Diagnostic Accuracy TEsts: the SEDATE guideline

(2016) A. Sotiriadis et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

A clinically applicable molecular-based classification for endometrial cancers

(2015) A Talhouk et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

(2015) I. C. van Gool et al.   CLINICAL CANCER RESEARCH

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

(2015) Ellen Stelloo et al.   MODERN PATHOLOGY

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

(2015) Brooke E. Howitt et al.   JAMA Oncology

Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas

(2013) Lien N. Hoang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

(2013) C. Blake Gilks et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE